亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer

作者
Douglas W. Blayney,Qingyuan Zhang,Jifeng Feng,Yanqiu Zhao,Igor Bondarenko,Ihor O. Vynnychenko,Nadezhda Vitalievna Kovalenko,Santosh M. Nair,Emad N. Ibrahim,Dmitriy Petrovich Udovista,Ramon W. Mohanlal,Stephan Ogenstad,Ene Ette,Lihua Du,Lan Huang,Yuankai Shi
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:6 (11): e204429-e204429 被引量:31
标识
DOI:10.1001/jamaoncol.2020.4429
摘要

IMPORTANCE: Plinabulin is a novel, non-granulocyte colony-stimulating factor (GCSF) small molecule with both anticancer and neutropenia-prevention effects. OBJECTIVE: To assess the efficacy and safety of plinabulin compared with pegfilgrastim for the prevention of chemotherapy-induced neutropenia following docetaxel chemotherapy in patients with non-small lung cancer. DESIGN, SETTING, AND PARTICIPANTS: This was a randomized, open-label, phase 2 clinical trial of 4 treatment arms that was conducted in 19 cancer treatment centers in the United States, China, Russia, and Ukraine. Participants were adult patients with non-small cell lung cancer whose cancer had progressed after platinum-based chemotherapy. Data were collected from April 2017 through March 2018 and analyzed from August 2019 through February 2020. INTERVENTIONS: All patients received docetaxel 75 mg/m2 on day 1 and were randomly assigned to 1 of 3 doses of plinabulin (5, 10, or 20 mg/m2) on day 1 or to pegfilgrastim 6 mg on day 2. Patients were treated every 21 days for 4 chemotherapy cycles. MAIN OUTCOMES AND MEASURES: The primary end point was the determination of the recommended phase 3 dose of plinabulin based on the days of severe neutropenia during chemotherapy cycle 1. Daily complete blood cell counts and absolute neutrophil counts were drawn during times of anticipated neutropenia during cycle 1. RESULTS: Of the 55 patients randomized and evaluated, the mean (SD) age was 61.3 (10.2) years, and 38 (69.1%) were men. With each escalation of the plinabulin dose, the incidence of any grade of neutropenia decreased. There were no significant differences in mean (SD) days of severe neutropenia among those treated with pegfilgrastim (0.15 [0.38] days) when dosed at day 2 vs plinabulin 20 mg/m2 (0.36 [0.93] days; P = .76) when dosed at day 1, and no safety signals were detected. CONCLUSIONS AND RELEVANCE: Single dose-per-cycle plinabulin has a similar neutropenia protection benefit as pegfilgrastim. Plinabulin 40 mg fixed dose, which is pharmacologically equivalent to 20 mg/m2, will be compared with pegfilgrastim 6 mg in the phase 3 portion of this trial. Noninferior days of severe neutropenia will be the primary end point, and bone pain reduction, thrombocytopenia reduction, and quality of life maintenance will be secondary end points. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03102606.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
5秒前
A水暖五金批发张哥完成签到,获得积分10
5秒前
Ni完成签到 ,获得积分10
6秒前
云墨完成签到 ,获得积分10
6秒前
7秒前
椰子云发布了新的文献求助10
9秒前
学术雷锋发布了新的文献求助10
12秒前
Moon完成签到 ,获得积分10
16秒前
天真的乐驹完成签到 ,获得积分10
20秒前
李健的小迷弟的应助被郦稀采纳,获得10
20秒前
Moon关注了科研通微信公众号
20秒前
21秒前
乐康完成签到,获得积分10
21秒前
24秒前
复杂惜珊完成签到,获得积分10
31秒前
cx完成签到,获得积分10
36秒前
机灵伟诚完成签到,获得积分10
36秒前
学霸业的应助被纯情的阁采纳,获得10
38秒前
极限001的应助被纯情的阁采纳,获得50
38秒前
Maestro_S的应助被纯情的阁采纳,获得10
38秒前
Nikkie2411的应助被纯情的阁采纳,获得10
38秒前
41秒前
42秒前
369ninja的应助被科研通管家采纳,获得10
44秒前
丘比特的应助被科研通管家采纳,获得10
44秒前
手打鱼丸完成签到 ,获得积分10
44秒前
44秒前
完美世界的应助被科研通管家采纳,获得10
44秒前
莫名乐乐完成签到,获得积分10
44秒前
FashionBoy的应助被科研通管家采纳,获得10
44秒前
SciGPT的应助被科研通管家采纳,获得10
44秒前
Akim的应助被纯情的阁采纳,获得10
44秒前
null的应助被科研通管家采纳,获得10
44秒前
45秒前
隐形曼青的应助被纯情的阁采纳,获得10
45秒前
null的应助被科研通管家采纳,获得10
45秒前
wanci的应助被科研通管家采纳,获得30
45秒前
大个的应助被纯情的阁采纳,获得30
45秒前
45秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158598
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719087
捐赠科研通 7748128
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551902
邀请新用户注册赠送积分活动 2471277